Gemtuzumab ozogamicin for relapsed and refractory acute myeloid leukemia and myeloid sarcomas.
Piccaluga PP, Martinelli G, Rondoni M, Malagola M, Gaitani S, Isidori A, Bonini A, Gugliotta L, Luppi M, Morselli M, Sparaventi G, Visani G, Baccarani M.
Piccaluga PP, et al. Among authors: visani g.
Leuk Lymphoma. 2004 Sep;45(9):1791-5. doi: 10.1080/1042819042000219485.
Leuk Lymphoma. 2004.
PMID: 15223637
Clinical Trial.